The Breast Cancer Steering Committee (BCSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult breast cancer. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The BCSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-Chairs
Shelley Hwang, M.D., M.P.H.
Duke University Medical Center
Antonio Wolff, M.D.
Johns Hopkins University
Members
Carmen Allegra, M.D.
National Cancer Institute, CTEP
Kimberly Allison, M.D.
Stanford University Medical Center
Karla Ballman, Ph.D.
Mayo Clinic
Judy Boughey, M.B. B.Chir.
Mayo Clinic
Thelma Brown
Patient Advocate
Lisa Carey, M.D.
University of North Carolina at Chapel Hill
Stephen Chia, M.D.
British Columbia Cancer Agency
Angela DeMichele, M.D., M.S.C.E.
University of Pennsylvania, Perelman School of Medicine
Jared Foster, Ph.D.
National Cancer Institute
Takeo Fujii, M.D., M.P.H.
National Cancer Institute
Jami Fukui, M.D.
Kapiolani Medical Center for Women & Children
Lisa R. Hayes, J.D.
Pink-4-Ever Ending Disparities
Chen Hu, Ph.D.
Johns Hopkins University
Reshma Jagsi, M.D., D.Phil.
Emory University
Christine Anne Koch, M.D., Ph.D.
University Health Network, Princess Margaret Cancer Centre
Amy K. Krie, M.D.
Allina Health Cancer Institute
Stanley Lipkowitz, M.D., Ph.D.
National Cancer Institute
Ben Park, M.D., Ph.D.
Vanderbilt University
Ann Partridge, M.D., M.P.H.
Dana-Farber Cancer Institute, Harvard University
Lajos Pusztai, M.D., D.Phil.
Yale University
Padma Sheila Rajagopal, M.D., M.P.H., M.Sc.
National Cancer Institute
Priya Rastogi, M.D.
University of Pittsburgh
Mothaffar Rimawi, M.D.
Baylor College of Medicine
Kathryn Ruddy, M.D.
Mayo Clinic
Bryan P. Schneider, M.D.
Indiana University, Simon Cancer Center
Priyanka Sharma, M.D.
University of Kansas Medical Center
Sara Tolaney, M.D., M.P.H.
Dana-Farber Cancer Institute, Harvard University
Fengmin Zhao, M.S., M.H.S., Ph.D.
Dana-Farber Cancer Institute, Harvard University
NCI CCCT Program Director
Laurie Shuman Moss, Ph.D.
laurie.shumanmoss@nih.gov